ST MARYS GOOD SAMARITAN — History
CCN 111329 | 3-year financial timeline | COVID resilience: 75/100
🛡️ Public data only — no PHI permitted on this instance.
$31M
Latest Revenue (FY2022)
+8.3%
Revenue CAGR (3yr)
2.5%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $26M | $30M | $31M | +3.1% | +8.3% |
| Operating Expenses | $28M | $30M | $30M | -0.7% | +3.9% |
| Operating Margin | -6.0% | -1.3% | 2.5% | +294.5% | +0.0% |
| Net Income | $-2M | $-0M | $1M | +300.5% | +0.0% |
| Licensed Beds | 25 | 25 | 25 | +0.0% | +0.0% |
| Total Patient Days | 5,515 | 5,165 | 4,191 | -18.9% | -12.8% |
| Medicare Day % | 40% | 40% | 41% | +2.2% | +1.3% |
| Medicaid Day % | 5% | 5% | 3% | -41.8% | -27.6% |
COVID Impact & Recovery
Resilience Score: 75/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +17.3% ($26M → $31M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+8.3%
This Hospital
+7.6%
State Avg
Latest Margin
2.5%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $33M | 6.7% |
| FY2024 (proj) | $36M | 11.0% |
| FY2025 (proj) | $38M | 15.2% |